The intoxication of eukaryotic cells by microbial and plant toxins involves the following steps: (i) binding of these proteins to their respective cell-surface receptors, (ii) receptor-medicated endocytosis of the receptor/toxin complex into endocytic vesicles, and (iii) the facilitated delivery of their respective catalytic domains to the eukaryotic cell cytosol. Of all these processes, the fundamental mechanisms involved in the delivery of the catalytic domain to the cytosol is the least well understood.
The specific aims of this proposal are focused on the analysis of transmembrane domain and catalytic domain mutants which are defective in the translocation of the catalytic domain to the cytosol of target cells. We propose the construction and analysis of epitope tagged mutants in the fusion toxin DAB389IL-2 to gain further insight into the mechanism of translocation. The recent development of an in vitro catalytic domain translocation assay using purified endocytic vesicles offers a powerful new assay in the study of this process. Since this system requires ATP and cytosolic factors, it is likely that we should uncover toxin/target cell protein interactions that were hither to unknown. DAB389-IL2 is extremely potent (e.g., IC50 < 5 x 10-12 M for target cells which carry the high affinity IL-2 receptor) and the difference between receptor-mediated and non-specific toxicity is > 5-logs of fusion toxin concentration. In addition, the level of non-specific binding of this system has allowed the detection of subtle changes in the interaction between the fusion protein and the target cell. Since DAB389-IL2 and diphtheria toxin appear to follow an identical route of entry into the cell, we believe that an increased understanding of the facilitated delivery of the catalytic domain will be broadly applicable to the delivery of other microbial and plant toxins.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA060934-08
Application #
6376021
Study Section
Bacteriology and Mycology Subcommittee 2 (BM)
Program Officer
Forry-Schaudies, Suzanne L
Project Start
1993-09-28
Project End
2002-04-30
Budget Start
2001-05-01
Budget End
2002-04-30
Support Year
8
Fiscal Year
2001
Total Cost
$233,988
Indirect Cost
Name
Boston Medical Center
Department
Type
DUNS #
005492160
City
Boston
State
MA
Country
United States
Zip Code
02118
Francis, Jonathan W; Figueiredo, Dayse; vanderSpek, Johanna C et al. (2004) A survival motor neuron:tetanus toxin fragment C fusion protein for the targeted delivery of SMN protein to neurons. Brain Res 995:84-96
Ratts, Ryan; Zeng, Huiyan; Berg, Eric A et al. (2003) The cytosolic entry of diphtheria toxin catalytic domain requires a host cell cytosolic translocation factor complex. J Cell Biol 160:1139-50
Hu, H Y; Huynh, P D; Murphy, J R et al. (1998) The effects of helix breaking mutations in the diphtheria toxin transmembrane domain helix layers of the fusion toxin DAB389IL-2. Protein Eng 11:811-7
vanderSpek, J C; Sutherland, J A; Zeng, H et al. (1997) Inhibition of protein synthesis in small cell lung cancer cells induced by the diphtheria toxin-related fusion protein DAB389 GRP. Cancer Res 57:290-4
Fisher, C E; Sutherland, J A; Krause, J E et al. (1996) Genetic construction and properties of a diphtheria toxin-related substance P fusion protein: in vitro destruction of cells bearing substance P receptors. Proc Natl Acad Sci U S A 93:7341-5
vanderSpek, J C; Sutherland, J A; Ratnarathorn, M et al. (1996) DAB389 interleukin-2 receptor binding domain mutations. Cytotoxic probes for studies of ligand-receptor interactions. J Biol Chem 271:12145-9
Murphy, J R; vanderSpek, J C (1995) Targeting diphtheria toxin to growth factor receptors. Semin Cancer Biol 6:259-67
vanderSpek, J; Cassidy, D; Genbauffe, F et al. (1994) An intact transmembrane helix 9 is essential for the efficient delivery of the diphtheria toxin catalytic domain to the cytosol of target cells. J Biol Chem 269:21455-9
vanderSpek, J C; Howland, K; Friedman, T et al. (1994) Maintenance of the hydrophobic face of the diphtheria toxin amphipathic transmembrane helix 1 is essential for the efficient delivery of the catalytic domain to the cytosol of target cells. Protein Eng 7:985-9